A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

A Surrey man with terminal brain cancer has been enrolled on a new medical treatment trial. Max Vardy, from Farnham, was ...

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first ...

研究首次构建了以IFI16为核心的“细胞衰老-铁死亡逃逸”的分子调控网络，并针对性的发现了新型胶质瘤辐射增敏药物，为胶质瘤辐射抵抗形成机制提供了全新理论框架，有望成为基础研究向临床转化的重要桥梁。

Concomitant radiotherapy plus temozolomide significantly increased progression-free survival versus radiotherapy alone in IDH ...

The University of Southern California (USC) has received a $6m grant from the California Institute for Regenerative Medicine ...

Katherine Webster was told she had months to live when she was diagnosed with a grade four glioblastoma in March 2020, aged ...

The first patients with a deadly and incurable form of brain cancer have been enrolled on a trial that could pave the way for personalised treatments for the disease. The research being conducted ...

Glioblastoma Multiforme Treatment Market size is expected to reach USD 4.7 Billion by 2033 from USD 2.2 Billion in 2023, at a CAGR of 8.1%. Lawrence John Prudour +91 91308 55334 ...

"Imvax secures $29m to support Phase IIb glioblastoma therapy trial" was originally created and published by Clinical Trials ...